Community Health Systems Inc
CYHNYSECIK 1108109HealthcareFiscal year ends Dec 31
Reports and events: 424 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:30 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001193125-26-437869 |
| 2026-10-2816:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-436229 |
| 2026-07-2316:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-314196 |
| 2026-07-2216:33 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-312454 |
| 2026-06-0116:30 ET | 8-K | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-251540 |
| 2026-05-1316:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-221742 |
| 2026-05-0616:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-208926 |
| 2026-04-2320:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-171305 |
| 2026-04-2216:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-170557 |
| 2026-04-2116:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-167000 |
| 2026-04-0216:30 ET | DEF 14A | Proxy statementPeriod 2026-03-31 | 0001193125-26-140269 |
| 2026-04-0116:30 ET | 8-K | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-138026 |
| 2026-03-0517:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-094191 |
| 2026-02-1916:32 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-059509 |
| 2026-02-1816:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-057162 |
| 2026-02-1116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-046661 |
| 2026-02-0216:30 ET | 8-K | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-033755 |
| 2026-01-2016:40 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-016693 |
| 2025-12-1016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-314292 |
| 2025-12-0216:44 ET | 8-K | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-305375 |
| 2025-10-3117:36 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-258896 |
| 2025-10-2416:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-250030 |
| 2025-10-2316:32 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-248834 |
| 2025-09-3017:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-225272 |
| 2025-09-1017:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-114028 |
| 2025-08-1217:22 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-179099 |
| 2025-07-2921:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-166943 |
| 2025-07-2416:22 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-098357 |
| 2025-07-2316:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-097895 |
| 2025-07-2316:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-097894 |
| 2025-07-2216:47 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-097594 |
| 2025-07-0116:30 ET | 8-K | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-092262 |
| 2025-05-1416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-071500 |
| 2025-05-0916:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-116904 |
| 2025-05-0716:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-114923 |
| 2025-04-2416:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-058115 |
| 2025-04-2316:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-091452 |
| 2025-04-2316:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-091442 |
| 2025-04-2316:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-057457 |
| 2025-04-1516:32 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-054276 |
| 2025-04-0316:30 ET | DEF 14A | Proxy statementPeriod 2025-04-01 | 0000950170-25-050483 |
| 2025-04-0116:30 ET | 8-K | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-048582 |
| 2025-03-0316:30 ET | 8-K | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-030906 |
| 2025-02-1916:31 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-023242 |
| 2025-02-1816:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-022328 |
| 2025-02-1416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-021297 |
| 2024-12-3116:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-141627 |
| 2024-12-1116:31 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-135399 |
| 2024-11-2616:30 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-131062 |
| 2024-11-2216:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-130250 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:46 ET. Listed shows no prices and gives no investment advice.